Finally, mir-221 and mir-222 are reported to be involved in lung cancer by targeting PTEN and TIMP3 tumor suppressors, inducing TRAIL resistance and enhancing cellular migration [75, 76]. This evidence concerns the gene PTEN and lung carcinoma.